Max Healthcare Institute Technical Momentum Shifts Amid Mixed Indicator Signals

The current price of Max Healthcare stands at ₹1,120.00, slightly below the previous close of ₹1,121.90. The stock’s 52-week range spans from ₹938.05 to ₹1,314.30, with intraday fluctuations between ₹1,114.15 and ₹1,145.65 on the latest trading day. Despite a marginal day change of -0.17%, the technical landscape reveals deeper shifts.

Examining the Moving Average Convergence Divergence (MACD) indicator, the weekly chart signals a bearish momentum, while the monthly chart shows a mildly bearish stance. The Relative Strength Index (RSI) does not currently indicate a clear signal on either weekly or monthly timeframes, suggesting a neutral momentum in the short to medium term. Bollinger Bands present a mildly bearish outlook on the weekly scale but shift to mildly bullish on the monthly scale, indicating some divergence in volatility and price movement expectations.

Further technical indicators reinforce this mixed picture. The daily moving averages align with a bearish trend, while the Know Sure Thing (KST) oscillator reflects bearish momentum weekly and mildly bearish monthly. Dow Theory analysis shows a mildly bearish trend on the weekly chart but no definitive trend on the monthly chart. On-Balance Volume (OBV) also signals mild bearishness weekly, with no clear trend monthly, highlighting subdued volume support for price movements.

From a broader market perspective, Max Healthcare’s returns compared to the Sensex reveal varied performance across timeframes. Over the past week, the stock returned 2.24%, outpacing the Sensex’s 0.96%. However, over the last month, the stock recorded a negative return of -6.85%, contrasting with the Sensex’s positive 0.86%. Year-to-date figures show the stock marginally trailing the Sensex, with returns of -0.67% versus 8.36%. Over longer horizons, Max Healthcare’s returns have been more robust, with a 12.01% gain over one year compared to the Sensex’s 9.48%, and a substantial 162.39% over three years against the Sensex’s 37.31%. The five-year return is particularly notable at 834.89%, significantly exceeding the Sensex’s 91.65% over the same period.

Max Healthcare’s market capitalisation grade remains at the lowest level, reflecting its relative size within the hospital sector. The Mojo Score currently stands at 43.0, with a recent adjustment in evaluation noted on 31 October 2025, shifting from a previous hold stance to a sell grade. This change was triggered by technical parameters on 19 November 2025, underscoring the influence of momentum and trend shifts on the stock’s assessment.

Investors analysing Max Healthcare should consider the nuanced signals from technical indicators alongside the stock’s historical performance relative to the broader market. While some indicators suggest bearish momentum in the short term, longer-term returns have demonstrated significant growth compared to the Sensex benchmark. The mixed signals from MACD, RSI, Bollinger Bands, and moving averages highlight the importance of a comprehensive approach when evaluating this hospital sector stock’s potential trajectory.

Overall, Max Healthcare Institute’s technical parameters reveal a transition phase with momentum shifts that warrant close monitoring. The interplay of bearish and mildly bullish signals across different timeframes suggests that price action may remain volatile, requiring investors to weigh both technical and fundamental factors carefully.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →